Project Grant HT94252410618
Award Date
6/15/24
Completion Date
6/14/26
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Finland
Similar Awards
The Defense Health Agency awarded a $1,973,398 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Azevan Pharmaceuticals Inc. in Bethlehem, PA. The grant supports the development of a new drug to prevent the effects of mild traumatic brain injury (TBI) or concussion. The research project will be conducted over a 2-year period from June 2024 to June 2026. The goal is to advance the development of an innovative medical solution to address this critical...
The Defense Health Agency awarded a $1,131,357 Project Grant titled "MicroRNA Biomarkers of Cumulative Blast-Mild Traumatic Brain Injury (Micro BCB)" under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by the Seattle Institute for Biomedical and Clinical Research, a non-profit institute, to investigate the use of microRNA biomarkers for detecting and monitoring the impact of mild traumatic brain injury related to blast...
This Project Grant award of $613,585.00 from the Defense Health Agency (DHA) supports research by James Cook University's Australian Institute of Tropical Health and Medicine to develop point-of-injury intranasal drug therapies to reduce secondary injury and improve outcomes for individuals with traumatic brain injuries (TBIs) in civilian and military resource-limited environments. This research falls under the DHA's Military Medical Research and Development program (CFDA 12.420), which...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
The Washington University Office of Sponsored Research Services Division was awarded a $1,377,119 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct the study "AD GENETIC RISK AS A PROGNOSTIC FACTOR FOR COGNITIVE OUTCOMES AFTER TBI" over a 4-year period from September 2024 to September 2028. This federal grant supports innovative biomedical research aimed at improving health outcomes for military service...
The Defense Health Agency awarded a $749,905 Project Grant to The Roskamp Institute Inc. under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to investigate microglial NOX2/NLRP3 inflammasome activation and its role in driving tau pathology and cognitive impairments in chronic traumatic brain injury. Specifically, the Roskamp Institute will conduct basic, applied, and advanced biomedical...
This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
The University of Pittsburgh was awarded a $569,851 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective from July 1, 2025 to June 30, 2029, will support research to assess the effectiveness of a traumatic brain injury whole blood test in improving the evaluation and triage of patients with mild traumatic brain injury presenting to civilian emergency departments. The Military Medical Research and Development...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,314,065.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the "Dose-Response Relationship of Acute TBI Blood Biomarkers with Pathoanatomic Neuroimaging Findings". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research on...
The federal Project Grant award of $837,500.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by The Feinstein Institutes for Medical Research on "OXYGEN CONSERVING REFLEX: A NOVEL MULTIMECHANISTIC THERAPEUTIC INTERVENTION FOR TBI." The research will investigate an innovative approach to address traumatic brain injury (TBI) by examining a novel oxygen conserving reflex. The award will support this...